Covid-19 vaccine update: Bharat Biotech to launch candidate in Q2 2021, Israel starts human trials | World News - Hindustan Times
close_game
close_game

Covid-19 vaccine update: Bharat Biotech to launch candidate in Q2 2021, Israel starts human trials

Hindustan Times, New Delhi | Byhindustantimes.com | Edited by Karan Manral
Nov 02, 2020 08:17 AM IST

AstraZeneca, meanwhile, has said Britain’s health regulator has started an ‘accelerated’ review. Its vaccine candidate is called ‘AZD1222’ and is being developed in partnership with the University of Oxford.

The number of cases of the coronavirus disease (Covid-19) is nearing the 50 million mark across the world and the death toll has risen to more than 1.2 million, according to a worldometers tally, even as the global hunt to find a vaccine against the infection continues. Vaccine candidates of several companies are at various stages of trials meaning that it might take some more time before the world eventually gets its first shot against Covid-19.

Vials with a sticker reading, "Covid-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed AstraZeneca logo in this illustration taken October 31, 2020 (REUTERS/Dado Ruvic/Illustration)
Vials with a sticker reading, "Covid-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed AstraZeneca logo in this illustration taken October 31, 2020 (REUTERS/Dado Ruvic/Illustration)

Click here for full Covid-19 coverage

Hindustan Times - your fastest source for breaking news! Read now.

The pandemic, meanwhile, continues to surge across Europe, after a brief lull in cases. Prime Minister Boris Johnson of the United Kingdom has announced a new four-week lockdown in England, which will come into effect from Thursday. Also, the World Health Organization’s (WHO’s) director general Tedros Adhanom Ghebreyesus said on Sunday he had been identified as a contact of someone who tested positive for Covid-19.

Read: UK’s Johnson says there is no alternative to lockdown


Here are the latest updates on a potential Covid-19 vaccine:

1. India’s Bharat Biotech International Limited on Sunday said it is planning to launch its vaccine candidate in the second quarter of 2021, after getting approval from regulatory authorities. The Hyderabad-based company said it plans to conduct recruitment and dosage for the third phase of its vaccine trials in November. Sai Prasad, Bharat Biotech’s executive director, said the trial will take place in 25 sites across 10-12 states in the country. During the trials, two doses each for the vaccine and placebo recipients will be provided.

Read: WHO chief says he is identified as contact of Covid-19 positive person

2. A global study has said India has used its manufacturing capabilities to pre-order 600 million doses of the Covid-19 vaccine and is negotiating for another billion. The doses, says the study, are enough to vaccinate at least half the population. Only the United States, which has the highest number of cases, has pre-ordered more doses--810 million-- than the second worst-hit India. Most experimental Covid-19 vaccines require two doses.

Read: Global study sees India having edge in Covid-19 vaccines

3. Israel has started human trials for its Covid-19 vaccine candidate, with 80 volunteers participating in the initial phase. The number of volunteers will be expanded to 960 by December. If the first two phases are successful, a third phase will be launched in April/May 2021 with 30,000 volunteers. If these trials are successful, the vaccine will be ready for the general public by the end of next summer.

(4.) 4. AstraZeneca Inc, which is among the companies testing a vaccine candidate, has said Britain’s health regulator has started an ‘accelerated’ review of its potential vaccine. AstraZeneca is working on the vaccine along with the University of Oxford and their vaccine candidate is called ‘AZD1222’ or ‘ChAdOx1 nCoV-19.’ In an ‘accelerated’ review, also called a ‘rolling’ review, regulators can view clinical data in real-time and talk to drug makers on the manufacturing process and trials to accelerate the approval process.

Unlock a world of Benefits with HT! From insightful newsletters to real-time news alerts and a personalized news feed – it's all here, just a click away! - Login Now!

Get Latest World News along with Latest News from India at Hindustan Times.
SHARE THIS ARTICLE ON
Share this article
SHARE
Story Saved
Live Score
OPEN APP
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Friday, March 29, 2024
Start 14 Days Free Trial Subscribe Now
Follow Us On